patient_id,note_date,index_date,eligible_label,ineligible_reasons,age,sex,race_ethnicity,height_cm,weight_kg,bmi,smoking_status,alcohol_use,outpatient_visits_last_12m,diagnoses,medications,allergies,pregnancy_status,recent_cardiovascular_event_6m,systemic_steroids_chronic,active_malignancy_systemic_tx_12m,narrative_note
P0009,2025-12-06,2025-12-07,INELIGIBLE,Type 1 diabetes (exclusion),44,Female,Middle Eastern,166,131,47.5,Never,None,2,Type 1 diabetes mellitus; Hypertension; Hyperlipidemia,Insulin glargine 24 units nightly; Insulin aspart with meals; Atorvastatin 10 mg daily,NKDA,Not pregnant,No,No,No,44-year-old Female with a history of type 2 diabetes diagnosed 4 years ago. Seen for routine outpatient follow-up. Reports no acute complaints. Current therapy: Insulin glargine 24 units nightly; Insulin aspart with meals; Atorvastatin 10 mg daily. Home glucose readings: fasting 120â€“160 mg/dL. Comorbidities: hypertension; dyslipidemia. Denies hypoglycemia requiring assistance. Last HbA1c on 2025-12-07 was 8.9%. Plan: continue basal-bolus insulin; review CGM data; follow-up in 3 months. Not eligible for cohort due to: Type 1 diabetes (exclusion).
